The patients will be recruited from 18-75 year old male or female patients undergoing hallux valgus or hallux rigidus surgery. MedDRA version: 9.1 Level: LLT Classification code 10019095 Term: Hallux Valgus correction MedDRA version: 9.1 Level: LLT Classification code 10019092 Term: Hallux rigidus
Conditions
Interventions
Trade Name: Durogesic
Pharmaceutical Form:
INN or Proposed INN: FENTANYL
CAS Number: 437387
Pharmaceutical form of the placebo: Transdermal patch
Route of administration of the placebo: Transdermal
Sponsors
Riika Merivirta
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: ;Secondary Objective: ;Primary end point(s): | — |
Countries
Finland
Outcome results
None listed